Study for the validation of the FeetMe® integrated sensor insole system compared to GAITRite® system to assess gait characteristics in patients with multiple sclerosis.
Anabel Granja DomínguezRaúl Romero SevillaAurora AlemánCarmen DuránAnja HochsprungGuillermo NavarroCristina PáramoAna VenegasAna LladonosaGuillermo Izquierdo AyusoPublished in: PloS one (2023)
Agreement between devices was strong (ICC≥0.800). FeetMe® is the first validated wearable medical device that allows gait monitoring in MS subjects, being potentially able to assess disease activity, progression, and treatment response.